We tested the hypothesis that term and preterm infants exposed to maternal infection at the time of delivery are at increased risk of developing cerebral palsy (CP).
INTRODUCTION
Cerebral palsy (CP) is a nonprogressive and chronic developmental motor disability. CP affects approximately 15/1000 infants weighing <2500 g at birth and increased in prevalence in the 1970s and 1980s possibly due to the increased survival of low birth weight and very low birth weight infants. 1 Term infants have a relatively low absolute risk of developing CP, but, because the majority of births are term, they account for about half the births of children with CP. 2 Prevalence of CP in term infants has remained about 1.3 to 1.5 per 1000 live births. 3 The etiology of CP remains poorly understood. Although commonly assumed associated with asphyxia, CP does not follow most cases of perinatal asphyxia, and most cases of CP are not associated with severe intrapartum asphyxia. Several risk factors have been associated with CP and include low gestational age, multiple gestation, intrauterine viral infections, congenital malformations, coagulation disorders, and intrauterine growth restriction. 4 Maternal infection has recently been implicated as a potential cause of CP. [5] [6] [7] The mechanisms are poorly understood and may be different in preterm and term infants. 8 Our objective was to test the hypothesis that both term and preterm infants exposed to maternal infection at the time of delivery are at increased risk of developing CP.
MATERIALS AND METHODS
The Human Subjects Protection Review Boards at the University of Washington and the Washington State Department of Health approved the procedures used in the conduct of this study. We conducted a population-based case-control study using linked hospital discharge-birth certificate data from Washington State. The Comprehensive Hospital Abstract Reporting System (CHARS), created by the Washington State Department of Health, contains records of all in-patient hospitalizations at nonfederal facilities within the state. Potential cases were identified by screening records of all hospitalizations during 1987 to 1999 for children r6 years to identify those with an ICD-9 code for CP (343.0 to 343.9) in one of several available discharge diagnosis fields. Records of the 768 children so identified were linked to the Birth Events Record Database (BERD) for 1982 to 1998, also created by the Washington State Department of Health, and containing linked birth certificate-hospital discharge data for the mother and child for the birth hospitalization. For 1999, a similar birth certificate-hospital discharge linkage was conducted, and records of potential cases were linked with this file for births occurring during 1999. For comparison, control children (no hospitalizations for CP) were identified by randomly selecting birth records for 1982 to 1999, at a control : case ratio of 4 : 1, which was chosen to increase the power of the study due to the limited sample size of cases. Multiple gestation pregnancies were excluded from analysis, resulting in a total of 688 cases and 3068 controls.
We measured exposure to maternal infection on the basis of ICD-9 codes recorded by the hospitals for the delivery admission, as well as data reported on the birth certificate. We were not able to obtain information on any exposure to infection that may have occurred during the pregnancy but prior to hospitalization for delivery. We evaluated four categories of exposure: (1) chorioamnionitis (ICD-9 codes: 762.7, or 658.4 for infection of the amniotic cavity); (2) urinary tract infection (UTI) as indicated by codes for infection of the kidney (590), cystitis (595), infection of the genitourinary tract in pregnancy (646.6), or UTI site not specified (599.0); (3) maternal fever (ICD-9 of 659.2, 672, and/or maternal or intrapartum fever >381C reported by check-box format on the birth certificate); and (4) maternal infection, which incorporates all of the above exposures as well as ICD-9 codes 647, 670, 672, 646.6, 658.4, 659.2, 659.3 under the category ''infections occurring during pregnancy, childbirth, or the puerperium'' (but only occurring during the hospitalization for delivery) and codes for ''general infections'' (001-139). Women may have had more than one type of infection. We evaluated the risks associated with the presence of these four categories of exposure relative to absence of any infection.
We calculated odds ratios (OR) and 95% confidence intervals (CI) to estimate the relative risk of CP associated with maternal infections. Using Mantel-Haenszel stratified analysis, the following potential confounders and/or effect modifiers obtained from the Birth Events Record Database were assessed for their effects in the relationships of interest: birth weight (>4000, 2500 to 3999, 1500 to 2499, <1500 g), gestational age (Z37, 33 to 36, 29 to 32, r28 weeks), gender, race, congenital anomalies, the presence of fetal distress at delivery, obstetrical complications such as abnormal presentation (breech), placenta previa, abruptio placenta, premature rupture of membranes, method of delivery (spontaneous vaginal, forceps, vacuum, cesarean section), and maternal characteristics such as age (<18, 18 to 19, 20 to 24, 25 to 29, 30 to 34, 35 þ years), number of prior births (0, 1, 2 þ ), prenatal smoking (no/yes) or alcohol use (no/yes), diabetes (no, established, gestational), marital status, and education (r12, 13 to 16, >16 years). A factor was considered a confounder after consideration of its relationship to the exposure and outcome, and if its adjusted and crude OR differed by more than 10%. Unless otherwise indicated, all risk estimates presented are adjusted for prenatal smoking because of this difference.
RESULTS
Women who gave birth to children with CP were generally similar to the mothers of the control group with respect to maternal race, parity, and the presence of diabetes (Table 1) . Mothers of children with CP were more likely to be <18 years old (8% of cases vs 3% of controls), unmarried (32 vs 22%), and were more likely to smoke (31 vs 20%) compared to controls. Mothers of children with CP were also less educated and reported a higher rate of prenatal alcohol use. A greater proportion of infants with CP were male (59%) than were controls (50%). In all, 39% of children with CP had a birth weight <2500 g compared to 4% of controls. Children with CP were also more likely to be of <37 weeks gestation compared to controls (38 vs 6%).
Having a maternal perinatal infection was associated with a three-fold increased risk of CP (OR 3.1, 95% CI 2.3 to 4.2) ( Table 2 ). Relative to the absence of any infection, increased risks were consistently associated with the presence of all infection categories examined, including chorioamnionitis (OR 5.8, 95% CI: 3.7 to 9.1), UTI (OR 4.0, 95% CI: 2.2 to 7.0), and maternal fever (OR 2.0, 95% CI: 1.1 to 3.5). These data included 259 infants for which gestational age was unavailable. In all, 46 were CP cases and five were exposed to maternal infection. This accounts for the greater OR of 3.1 among combined infants compared to an OR of 1.8 for term deliveries and 2.3 for preterm deliveries.
Approximately two-fold increased risks of CP were associated with the presence of any maternal infection among both term (OR 1.8, 95% CI: 1.1 to 2.8) and preterm deliveries (OR 2.3, 95% CI: 1.3 to 4.2). Among term deliveries, relative to the absence of any maternal infection, the presence of chorioamnionitis (OR 1.8, 95% CI: 0.8 to 4.4) or UTI (OR 2.2, 95% CI: 0.9 to 5.1) was associated with increased risks of CP which were, however, not statistically significant. Among preterm deliveries, the risks of CP associated with chorioamnionitis (OR 3.6, 95% CI: 1.5 to 8.4) or UTI (OR 4.8, 95% CI: 1.2 to 18.3) were markedly increased. The presence of maternal fever was not associated with an increased risk of CP either in term (OR 1.2, 95% CI: 0.5 to 2.8) or preterm deliveries (OR 1.1, 95% CI: 0.4 to 3.0).
To further clarify the relative effects of maternal infection and prematurity on the occurrence of CP, we stratified subjects on the presence or absence of these characteristics and calculated risk estimates relative to term infants of deliveries not complicated by maternal infection (Table 3 ). The risk of CP associated with preterm delivery, in the absence of maternal infection, was 8.3 (95% CI: 6.6 to 10.5); markedly greater than the two-fold increased risk associated with maternal infection among term deliveries. Preterm infants delivered in the presence of maternal infection had a risk of CP of 19.7 (95% CI: 12.8 to 30.2).
The infection-CP relationship among preterm infants was examined more closely by restricting the analysis to only those born at <37 weeks gestation. The risk of CP associated with maternal infection during the birth hospitalization was not increased among infants of 33 to 36 weeks gestation 1.0 (0.4 to 2.7) when compared to infants of 33 to 36 weeks gestation not exposed to maternal infection. In the absence of maternal infection, a gestational age of r32 weeks was associated with a risk of CP of 5.7 (95% CI: 3.4 to 9.5), relative to delivery at 33 to 36 weeks gestation. The risk of CP associated with maternal infection and gestational age of r32 weeks was 10.8 (95% CI: 4.8 to 24.3), relative to preterm births of 33 to 36 weeks gestation without infection. When data were further restricted to include only infants of r32 weeks gestation, the risk of CP associated with maternal infection among infants of r32 weeks gestation, relative to infants of r32 weeks gestation without infection, was 2.3 (95% CI: 1.2 to 4.5).
DISCUSSION
The major finding of this study is that maternal infection was associated with an approximately two-fold increased risk of CP in Chorioamnionitis and UTI were also associated with an increased risk of CP in preterm infants but not in term infants. Maternal fever was not associated with CP in either term or preterm infants and may not be a good proxy for infection. A major purpose of this study was to contribute to the paucity of data on CP among term infants. Although at least half of CP cases occur in term infants, only a few studies have examined infections as risk factors for CP in the term or near-term infant. 6, [9] [10] [11] [12] In a population-based case-control study of infants with a birth weight >2500 g, Grether and Nelson 6 reported that one or more indicators of maternal infection were present in 3% of control children compared to 22% of those with CP (OR 9.3; 95% CI 3.7 to 23.0), and 37% of those with spastic quadriplegia (OR 19.0; 95% CI 6.5 to 56.0). In a recent study of term and near-term infants born at Z36 weeks gestation, chorioamnionitis was associated with a fourfold increased risk of CP after exclusion of postnatal brain injury or known developmental or genetic abnormalities. 12 An association between infection and CP has been reported in preterm or low birth weight infants in several studies. [13] [14] [15] [16] [17] Several investigators have reported estimates of two-to four-fold increases in risk of CP associated with chorioamnionitis or maternal infection in preterm or very low birth weight infants, but not all reached statistical significance.
16,18 -21 For preterm infants, Wu and Colford 7 reported a summary relative risk of 1.9 (95% CI 1.4 to 2.5) for clinical chorioamnionitis and 1.6 (95% CI 0.9 to 2.7) for histologic chorioamnionitis in her meta-analysis. Utilizing the two studies on term infants, 6, 22 Wu and Colford 7 reported a summary relative risk of 4.7 (95% CI 1.3 to 16.2) for clinical chorioamnionitis and the risk of CP in term infants.
The effect of maternal infection on CP risk appears to be greater in preterm than in term infants, however, the relationship between gestational age and infection is complex. Maternal infection is a common cause of preterm birth, [23] [24] [25] as well as CP. However, preterm birth may be associated with CP through other, noninflammatory mechanisms as well. 26, 27 In our study, preterm delivery in the absence of infection was associated with an eightfold increase in risk of CP overall when compared to term noninfected infants. The risk of CP was 24-fold greater for the very preterm noninfected infants when compared to term non-infected infants. Low gestational age is a well-known risk factor for CP. [28] [29] [30] [31] We found that the combination of prematurity and infection to have a multiplicative effect on the risk of CP with a 20-fold increase in the risk of CP. This effect held true when we further stratified into very low gestational age infants. As expected, the risk of CP increases with decreasing gestational age, but the presence of maternal infection magnifies the risk. This may be due to the intrinsic vulnerability of the developing brain earlier in gestation. 32, 33 For instance, oligodendrocyte precursors have been found to be most susceptible to injury around 23 to 32 weeks postconceptual age. 34 Damage to the oligodendrocytes can impair myelination resulting in the ultrasound findings of periventricular leukomalacia and, ultimately, the clinical manifestations of CP.
Maternal fever is a poor proxy for maternal infection, and indeed, we found no association between maternal fever and risk of CP. Maternal fever has been associated with epidural analgesia and with an elevation in maternal and fetal cytokines. [35] [36] [37] However, it appears that the inflammatory response originates from the mother rather than the infant. Maternal fever is often considered to indicate chorioamnionitis, but without our ability to have histologic evidence of chorioamnionitis, infection by these criteria may have been overestimated, and, if no infection was present, would weaken the association.
There are several limitations to this study. During the years 1987 to 1993, when we had the full 6 years available for hospital admission to identify children with CP, the number of births in Washington State was approximately 80,000 per year. Based on the prevalence of CP of 1.2 to 2.3 per 1000, we would expect 96 to 184 cases of CP per year. During this 6-year period, we identified an average of about 55 cases per year. This method is likely to select the more severely affected cases of CP by excluding those without hospital admissions, or whose discharge records were not coded for CP, as well as possibly including some cases among the control group. This would bias our risk estimates towards the null. Patients with CP may have been missed because of poor coding, missed diagnoses, or alternative coding. Since CP presents over time in a developmental manner, infants may initially appear asymptomatic and several months later manifest evidence of CP. Likewise, some infants may have neurologic signs of CP early on that are transient and no motor impairment persists in later childhood. [38] [39] [40] Another limitation is that chorioamnionitis may have been under-reported because the diagnosis is detected histologically for a proportion of asymptomatic women. Furthermore, the clinical criteria for diagnosing chorioamnionitis are not well defined and vary among studies. In fact, in Wu's meta-analysis, no two studies used the same definition of clinical chorioamnionitis. 41 We have no reason to think there would be differential misclassification between cases and controls, therefore, our risk estimates remain valid but of reduced magnitude. In addition, we underestimated the true prevalence of maternal infection because we could not assess infection that occurred outside the period of delivery. This would also weaken the association between infection and CP if the mothers of children with CP exposed to maternal infection prior to admission for delivery were categorized as non-infected.
The use of ICD-9 diagnosis codes to identify children with CP and to identify maternal infections has significant limitations. The use of ICD-9 codes relies on the accuracy of hospital coders. We also do not have the ability to review the data or the patients for accuracy and there is no gold standard we can use. Inaccuracies in coding is likely to be omission of a code in a patient who actually has a diagnosis rather than overcoding and including a diagnosis that the patient does not have. This would bias the results toward the null.
We performed, to our knowledge, the largest population-based analysis of maternal infection and its association with CP comparing term and preterm infants. Maternal infection is a risk factor for CP in both term and preterm infants, posing a two-fold increased risk. These results support the hypothesis of a fetal inflammatory response to maternal infection resulting in fetal/ neonatal brain injury, possibly related to increased levels of inflammatory cytokines in amniotic fluid and blood of affected infants. Given the considerable debility and costs experienced by those affected, a clearer understanding of the possible etiologies and development of prevention strategies is warranted.
